No Data
No Data
Press Release: Harbour BioMed Reports Full Year 2023 Financial Results
Harbour BioMed Reports Full Year 2023 Financial Results PR Newswire CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, March 28, 2024 CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, C
Hebo Pharmaceutical-B (02142) announced annual results. Profit attributable to shareholders of US$22.797 million turned a year-on-year loss into a profit
Hebo Pharmaceutical-B (02142) announced results for the year ended December 31, 2023, and the group obtained revenue...
HBM HOLDINGS-B: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2023
Hebo Pharmaceutical-B (02142.HK) will hold a board meeting on March 28 to approve the annual results
On March 13, Gelonghui Pharmaceutical-B (02142.HK) announced that the company will hold a board meeting on March 28, 2024 to consider and approve the Group's annual results for the year ended December 31, 2023, and deal with other matters.
HBM HOLDINGS-B: DATE OF BOARD MEETING
HBM Holdings Subsidiary Signs Antibody-Drug Conjugate Discovery Collaboration Deal
HBM Holdings (HKG:2142) subsidiary Nona Biosciences signed an antibody-drug conjugate (ADC) discovery collaboration with Boostimmune to develop ADC therapy, a Tuesday filing said. Under the agreement,
No Data